Ambu A/S
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as… Read more
Ambu A/S (AMBFF) - Total Assets
Latest total assets as of June 2025: $7.40 Billion USD
Based on the latest financial reports, Ambu A/S (AMBFF) holds total assets worth $7.40 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ambu A/S - Total Assets Trend (2000–2024)
This chart illustrates how Ambu A/S’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Ambu A/S - Asset Composition Analysis
Current Asset Composition (September 2024)
Ambu A/S's total assets of $7.40 Billion consist of 36.9% current assets and 63.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.6% |
| Accounts Receivable | $789.00 Million | 11.0% |
| Inventory | $1.08 Billion | 15.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.70 Billion | 23.8% |
| Goodwill | $1.53 Billion | 21.3% |
Asset Composition Trend (2000–2024)
This chart illustrates how Ambu A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ambu A/S's current assets represent 36.9% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 8.6% of total assets in 2024, down from 40.2% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 44.0% of total assets, an increase from 42.0% in 2000.
- Asset Diversification: The largest asset category is intangible assets at 23.8% of total assets.
Ambu A/S Competitors by Total Assets
Key competitors of Ambu A/S based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Ambu A/S - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Ambu A/S generates 0.75x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Ambu A/S generates $ 3.28 in net profit.
Ambu A/S - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.90 | 2.52 | 1.19 |
| Quick Ratio | 1.73 | 1.51 | 0.69 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.93 Billion | $ 1.50 Billion | $ 197.00 Million |
Ambu A/S - Advanced Valuation Insights
This section examines the relationship between Ambu A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.42 |
| Latest Market Cap to Assets Ratio | 0.48 |
| Asset Growth Rate (YoY) | 4.3% |
| Total Assets | $7.15 Billion |
| Market Capitalization | $3.41 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Ambu A/S's assets below their book value (0.48 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Ambu A/S's assets grew by 4.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Ambu A/S (2000–2024)
The table below shows the annual total assets of Ambu A/S from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-09-30 | $7.15 Billion | +4.30% |
| 2023-09-30 | $6.86 Billion | -4.93% |
| 2022-09-30 | $7.21 Billion | +25.70% |
| 2021-09-30 | $5.74 Billion | +16.52% |
| 2020-09-30 | $4.93 Billion | +8.07% |
| 2019-09-30 | $4.56 Billion | +7.65% |
| 2018-09-30 | $4.23 Billion | +69.36% |
| 2017-09-30 | $2.50 Billion | +5.66% |
| 2016-09-30 | $2.37 Billion | +4.97% |
| 2015-09-30 | $2.25 Billion | +10.11% |
| 2014-09-30 | $2.05 Billion | +8.25% |
| 2013-09-30 | $1.89 Billion | +95.86% |
| 2012-09-30 | $965.51 Million | +8.59% |
| 2011-09-30 | $889.16 Million | +1.52% |
| 2010-09-30 | $875.87 Million | +12.05% |
| 2009-09-30 | $781.66 Million | +6.75% |
| 2008-09-30 | $732.22 Million | +7.56% |
| 2007-09-30 | $680.77 Million | +0.45% |
| 2006-09-30 | $677.74 Million | +3.00% |
| 2005-09-30 | $658.01 Million | +11.32% |
| 2004-09-30 | $591.11 Million | +6.31% |
| 2003-09-30 | $556.04 Million | -1.27% |
| 2002-09-30 | $563.20 Million | +6732.38% |
| 2001-09-30 | $8.24 Million | +63.51% |
| 2000-09-30 | $5.04 Million | -- |